ESC/EACTS Guidelines on myocardial revascularization, Eur Heart J, vol.40, pp.87-165, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02393795
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes, N Engl J Med, vol.361, pp.1045-1057, 2009. ,
Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial, Eur Heart J, vol.32, pp.2933-2944, 2011. ,
ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS), Eur Heart J, vol.39, issue.3, pp.213-260, 2017. ,
Killip classification in patients with acute coronary syndrome: insight from a multicenter registry, Am J Emerg Med, vol.30, pp.97-103, 2012. ,
Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry, Eur Heart J, vol.26, pp.2114-2119, 2005. ,
Prognostic Importance of Physical Examination for Heart Failure in Non-ST-Elevation Acute Coronary Syndromes, JAMA, vol.290, pp.2174-2181, 2003. ,
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies, PLoS Med, vol.4, issue.10, 2007. ,
, Observational Studies: Getting Clear about Transparency, The PLOS Medicine Editors, vol.11, issue.8, p.1001711, 2014.
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur Heart J, vol.33, pp.2569-2619, 2012. ,
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes, N Engl J Med, vol.357, 2001. ,
Fourth universal definition of myocardial infarction, Eur Heart J, vol.40, pp.237-269, 2018. ,
, J Am herat Assoc, vol.8, issue.8, p.11991, 2019.
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge, Circulation, vol.76, pp.142-154, 1987. ,
Propensity score model overfitting led to inflated variance of estimated odds ratios, J Clin Epidemiol, vol.80, pp.97-106, 2016. ,
Variable selection for propensity score models, Am J Epidemiol, vol.163, pp.1149-1156, 2006. ,
Competing Risks Regression for Stratified Data, Biometrics, vol.67, issue.2, p.21155744, 2011. ,
Competing risks regression for clustered data, Biostatistics, vol.13, issue.3, pp.371-383, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01125902
Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction. Results of the ISAR-SHOCK registry, Thromb Haemost, vol.112, pp.1190-1197, 2014. ,
ADP receptor antagonists in patients with acute myocardial infarction complicated by cardiogenic shock: a post hoc IABP-SHOCK II trial subgroup analysis, EuroIntervention, vol.10, issue.11, pp.1395-1403, 2016. ,
Treatment of myocardial infarction in a coronary care unit, Am J Cardiol, vol.20, p.6059183, 1967. ,
Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial, Am Heart J, vol.213, pp.57-65, 2019. ,
Perioperative outcomes of cardiac surgery patients with ongoing ticagrelor therapy: boon and bane of a new drug, Eur J Cardiothorac Surg, vol.46, pp.198-205, 2014. ,
Impact of Timing on the Functional Recovery Achieved With Platelet Supplementation After Treatment With Ticagrelor, Circ Cardiovasc Interv, vol.10, issue.8, 2017. ,
Effects of autologous platelet transfusion on platelet inhibition in ticagrelor-treated and clopidogrel-treated subjects, J Thromb Haemost, vol.14, pp.2342-2352, 2016. ,
Efficacy of Ex Vivo Autologous and In Vivo Platelet Transfusion in the Reversal of P2Y12 Inhibition by Clopidogrel, Prasugrel, and Ticagrelor: The APTITUDE Study, Circ Cardiovasc Interv, vol.8, issue.11, 2015. ,
Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes, J Am Coll Cardiol, vol.56, pp.1456-1462, 2010. ,
Hemostatic effects of the ticagrelor antidote MEDI2452 in pigs treated with ticagrelor on a background of aspirin, J Thromb Haemost, vol.15, pp.1213-1222, 2017. ,
Short term outcome following acute phase switch among P2Y12 inhibitors in patients presenting with acute coronary syndrome treated with PCI: A systematic review and meta-analysis including 22,500 patients from 14 studies, Int J Cardiol Heart Vasc, vol.22, pp.39-45, 2018. ,
Switching to Clopidogrel in Patients With Acute Coronary Syndrome Managed With Percutaneous Coronary Intervention Initially Treated With Prasugrel or Ticagrelor: Systematic Review and Meta-analysis, Ann Pharmacother, vol.53, pp.997-1004, 2019. ,
The impact of in-hospital P2Y12 inhibitor switch in patients with acute coronary syndrome, Cardiovasc Revasc Med, vol.19, pp.912-916, 2018. ,
Clopidogrel for Coronary Stenting: Response Variability, Drug Resistance, and the Effect of Pretreatment Platelet Reactivity, Circulation, vol.107, pp.2908-2913, 2003. ,
High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability, European Heart Journal, vol.25, pp.1903-1910, 2004. ,